Shearman & Sterling advised CVS Health Corporation (CVS Health) on its $40 billion bond offering to finance a portion of the purchase price for its acquisition…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
